BSW
IDXX icon

Buckingham Strategic Wealth’s Idexx Laboratories IDXX Stock Holding History

Buckingham Strategic Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.08M Sell
2,208
-23
-1% -$11.5K 0.01% 326
2024
Q1 		$1.2M Sell
2,231
-162
-7% -$88.5K 0.01% 306
2023
Q4 		$1.33M Buy
2,393
+147
+7% +$69K 0.02% 287
2023
Q3 		$982K Sell
2,246
-10
-0.4% -$4.99K 0.01% 294
2023
Q2 		$1.13M Sell
2,256
-10
-0.4% -$4.79K 0.02% 279
2023
Q1 		$924K Hold
2,266
– – 0.02% 280
2022
Q4 		$924K Sell
2,266
-128
-5% -$49.7K 0.02% 281
2022
Q3 		$780K Buy
2,394
+23
+1% +$8.45K 0.02% 289
2022
Q2 		$832K Sell
2,371
-214
-8% -$87.3K 0.02% 284
2022
Q1 		$1.41M Sell
2,585
-22
-0.8% -$11.6K 0.03% 231
2021
Q4 		$1.72M Sell
2,607
-161
-6% -$101K 0.03% 200
2021
Q3 		$1.72M Sell
2,768
-184
-6% -$124K 0.04% 188
2021
Q2 		$1.86M Sell
2,952
-129
-4% -$71.2K 0.05% 179
2021
Q1 		$1.51M Sell
3,081
-82
-3% -$41.1K 0.07% 188
2020
Q4 		$1.58M Buy
+3,163
New +$1.42M 0.08% 174

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Buckingham Strategic Wealth's IDXX Position: Q2 2024 in Review

Buckingham Strategic Wealth reduced its Idexx Laboratories (IDXX) stake by 1% in Q2 2024, selling an estimated $11.5K and leaving 2,208 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #326.

Buckingham Strategic Wealth first reported a position in IDXX in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.86M in Q2 2021. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

  • Buckingham Strategic Wealth held 2,208 shares of Idexx Laboratories worth $1.08M as of Q2 2024.
  • Buckingham Strategic Wealth sold 23 Idexx Laboratories shares in Q2 2024, an estimated $11.5K.
  • Idexx Laboratories made up 0.01% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #326 holding.
  • Buckingham Strategic Wealth first reported a position in Idexx Laboratories in Q4 2020 and has held it in 15 quarters since.
  • Buckingham Strategic Wealth's Idexx Laboratories position peaked at $1.86M in Q2 2021.
  • 1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.